CREO — Creo Medical Share News
0.000.00%
- £61.20m
- £52.90m
- £6.00m
First use of Speedboat® UltraSlim in Latin America
First use of Speedboat® UltraSlim in the USA
First European Speedboat® UltraSlim procedure
Brief: Creo Medical Group Receives US FDA Clearance For Its Speedboat Ultraslim Device
Speedboat® UltraSlim: US FDA Clearance
Brief: Creo Medical Group Says Speedboat Ultraslim EU Launch Accelerated By 18 Months
Investor Presentation
Brief: Creo Medical Group Posts H1 Gross Profit 7.5 Million Stg
Half-year Report
Notice of Results
Royal Oldham SSD service update
Brief: Creo Medical Group HY Revenue 15.7 Million Stg
Half Year Trading Update
Issue of Equity and TVR
Appointment of Marco Scarci
Posting of Annual Report and Notice of AGM
Brief: Creo Medical Group Reaches First In-Human Milestone For Microblate Flex
Royal Oldham Hospital Agreement
Attendance at Digestive Disease Week